Homepage
Asia & Pacific
Asia & Pacific Legal Chronicle
Matter YS Biopharma’s Merger with Summit Healthcare Acquisition Corp.

Matter YS Biopharma’s Merger with Summit Healthcare Acquisition Corp.

October 25, 2022 Martina Bellini

Tagged: 25-10-2022 Dan Ouyang Han Shen Ke Li Myra Sutanto Shen Wilson Sonsini Goodrich & Rosati Yisheng Biopharma Zhenzhen Bao

Wilson Sonsini represented YS Biopharma on the deal.YishengBio Co., Ltd (YS Biopharma), a commercialization-stage biopharmaceutical company focusing on innovative vaccines and therapeutic biologics, and Summit Healthcare…

This content is for Standard 1 Year members only.
Login Join Now

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now

View all posts by Martina Bellini

Hyland Software’s US$3.4 Billion Unitranche Facility Financing

Brightstar Capital’s Acquisition of Douglas Products

Skye Orthobiologics, LLC, et al. v. CTM Biomedical, LLC, et al.

Gringo’s BRL150 Million Investment Round

Aqua Capital’s Acquisition of Exata Holding

Saipem’s Sale and Purchase Agreement

AMEA Power’s First Solar IPP Project in El Metbassta (Tunisia)

XXXLutz Group’s Delisting of home24

ARK Invest’s Acquisition of Rize ETF

Eskom’s Closing of Oya and Umoyilanga Energy Deals

Post For Investment’s Acquisition of Roaderz Technologies

YANMU Logistics Park’s Financing Agreement with CIB

Panaxia Labs Israel’s Share Swap Agreement with the Barak Group

Menora Mivtachim’s Public Offering

International Schools Partnership’s Acquisition of The English College

Northland Power and Mitsui & Co’s Financing of 1,022MW Hai Long Offshore Wind Farm

LVGEM Real Estate’s Issuance of Guaranteed Commercial Paper Notes

Mongolian Mining’s Exchange Offer

Carlos Lobo Joins Arnold & Porter’s Corporate & Finance Practice in New York

Proskauer Continues Growth of Transactional Platform

Osborne Clarke Opens New Office in Miami with Javier Fernández-Samaniego

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Presumption of “Tax Inversion”: The Italian Supreme Court Clarifues That “Mediated” Control Is Not Relevant

Carlos Lobo Joins Arnold & Porter’s Corporate & Finance Practice in New York

Proskauer Continues Growth of Transactional Platform

Osborne Clarke Opens New Office in Miami with Javier Fernández-Samaniego

Matter YS Biopharma’s Merger with Summit Healthcare Acquisition Corp.

Author: Martina Bellini